VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q4 2022 | $12 | -99.9% | 104,219 | -5.5% | 0.00% | – |
| Q3 2022 | $17,000 | -88.1% | 110,298 | +23.5% | 0.00% | – |
| Q2 2022 | $143,000 | – | 89,307 | +40128.4% | 0.00% | – |
| Q3 2019 | $0 | – | 222 | -58.3% | 0.00% | – |
| Q2 2019 | $0 | – | 533 | +2.1% | 0.00% | – |
| Q1 2019 | $0 | – | 522 | -9.5% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 577 | -83.9% | 0.00% | – |
| Q2 2018 | $7,000 | +75.0% | 3,577 | +403.8% | 0.00% | – |
| Q3 2017 | $4,000 | -50.0% | 710 | -61.3% | 0.00% | – |
| Q2 2017 | $8,000 | – | 1,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,896,902 | $4,173,000 | 5.19% |
| Knoll Capital Management, LLC | 896,771 | $1,973,000 | 1.68% |
| SABBY MANAGEMENT, LLC | 1,856,169 | $4,084,000 | 0.63% |
| 683 Capital Management, LLC | 346,574 | $762,000 | 0.05% |
| Virtu Financial LLC | 64,203 | $141,000 | 0.01% |
| Spark Investment Management LLC | 29,300 | $64,000 | 0.00% |
| Alyeska Investment Group, L.P. | 83,333 | $183,000 | 0.00% |
| Burt Wealth Advisors | 1,674 | $4,000 | 0.00% |
| A.R.T. Advisors, LLC | 24,682 | $54,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 29,220 | $64,000 | 0.00% |